People
Find researchers
Who has published, run trials or held grants on a topic, and how to reach them through people they have worked with.
Ranked by expertise@1: every paper, trial or grant they worked on in scope counts, recent work counts more, and being first or last author or a trial’s principal investigator counts 1.5 times.
Researchers with CLDN18.2 work
238 researchers in CLDN18.2, best first; 151–175 shown.
- Xiaokang Zhangprovisional identity · First Affiliated Hospital of Soochow University
In CLDN18.2: 1 paper. Expertise score 0.85. 1 paper in all, 2025.
Topics: CLDN18.2, All pancreatic cancer
- Xiaoping Zhou · Yangtze University
In CLDN18.2: 1 paper. Expertise score 0.85. 1 paper in all, 2025.
Topics: CLDN18.2, All pancreatic cancer
- Yaru Zhao · Shanghai Jiao Tong University
In CLDN18.2: 1 paper. Expertise score 0.85. 4 papers in all, 2023–2025.
Topics: All pancreatic cancer, CLDN18.2, Early detection
- Ying Xing
In CLDN18.2: 1 paper. Expertise score 0.85. 1 paper in all, 2025.
Topics: CLDN18.2, All pancreatic cancer
- Yue Qingprovisional identity · Shanghai Jiao Tong University
In CLDN18.2: 1 paper. Expertise score 0.85. 1 paper in all, 2025.
Topics: CLDN18.2, All pancreatic cancer
- Yun Kyung Jung
In CLDN18.2: 1 paper. Expertise score 0.85. 3 papers in all, 2025.
Topics: All pancreatic cancer, CLDN18.2
- Dae Won Kim · Moffitt Cancer Center
In CLDN18.2: 1 trial. Expertise score 0.85. 3 papers, 2 trials in all, 2020–2026.
Topics: All pancreatic cancer, CLDN18.2
- Harry H Yoonprovisional identity · Mayo
In CLDN18.2: 1 trial. Expertise score 0.85. 1 trial in all, 2020.
Topics: CLDN18.2, All pancreatic cancer
- Jin Li · Shanghai East Hospital
In CLDN18.2: 1 trial. Expertise score 0.85. 1 paper, 3 trials in all, 2019–2023.
Topics: All pancreatic cancer, CLDN18.2, KRAS
- Professor Xianjun Yuprovisional identity · Fudan University
In CLDN18.2: 1 trial. Expertise score 0.85. 1 trial in all, 2020.
Topics: CLDN18.2, All pancreatic cancer
- Rui‐Hua Xu · Sun Yat-sen University Cancer Center
In CLDN18.2: 1 trial. Expertise score 0.85. 17 papers, 2 trials in all, 2012–2026.
Topics: All pancreatic cancer, KRAS, CLDN18.2
- BioNTech Responsible Personprovisional identity · BioNTech SE
In CLDN18.2: 1 trial. Expertise score 0.78. 9 trials in all, 2016–2025.
Topics: All pancreatic cancer, CLDN18.2
- Cassandra Choe-Juliakprovisional identity · Flame Biosciences
In CLDN18.2: 1 trial. Expertise score 0.78. 1 trial in all, 2022.
Topics: CLDN18.2, All pancreatic cancer
- Enxiao Li
In CLDN18.2: 1 paper. Expertise score 0.78. 3 papers in all, 2021–2022.
Topics: All pancreatic cancer, CLDN18.2
- Jiangfeng Suprovisional identity · Conjupro Biotherapeutics, Inc.
In CLDN18.2: 1 trial. Expertise score 0.78. 1 trial in all, 2022.
Topics: CLDN18.2, All pancreatic cancer
- Xiaoding Liu
In CLDN18.2: 1 paper. Expertise score 0.78. 13 papers in all, 2019–2026.
Topics: All pancreatic cancer, CLDN18.2, Early detection
- Zhiyong Liang · Peking Union Medical College Hospital
In CLDN18.2: 1 paper. Expertise score 0.78. 55 papers in all, 2015–2026.
Topics: All pancreatic cancer, CLDN18.2, Early detection, KRAS
- Alexander Ioannis Damanakis
In CLDN18.2: 1 paper. Expertise score 0.72. 11 papers in all, 2018–2025.
Topics: All pancreatic cancer, CLDN18.2, KRAS
- Dirk Waldschmidt
In CLDN18.2: 1 paper. Expertise score 0.72. 21 papers, 1 trial in all, 2013–2026.
Topics: All pancreatic cancer, CLDN18.2, KRAS
- Haoqi Zhang
In CLDN18.2: 1 paper. Expertise score 0.72. 1 paper in all, 2024.
Topics: CLDN18.2, All pancreatic cancer
- He Cheng · Shanghai Medical College of Fudan University
In CLDN18.2: 1 paper. Expertise score 0.72. 34 papers in all, 2015–2026.
Topics: All pancreatic cancer, KRAS, KRAS G12D, CLDN18.2
- Jiliang Zhao
In CLDN18.2: 1 paper. Expertise score 0.72. 3 papers in all, 2024–2025.
Topics: All pancreatic cancer, CLDN18.2
- Jun Yu · Johns Hopkins University
In CLDN18.2: 1 paper. Expertise score 0.72. 70 papers in all, 2012–2026.
Topics: All pancreatic cancer, KRAS, Early detection, KRAS G12D, CLDN18.2
- Jun Zhang · Shanghai Jiao Tong University
In CLDN18.2: 1 paper. Expertise score 0.72. 8 papers in all, 2014–2024.
Topics: All pancreatic cancer, KRAS, CLDN18.2, KRAS G12D
- Li Lin
In CLDN18.2: 1 paper. Expertise score 0.72. 3 papers in all, 2020–2025.
Topics: All pancreatic cancer, CLDN18.2, KRAS